Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated Idylla™ platform MRC Technology (‘MRCT’), a medical research charity, and Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today announced a partnership to develop ...
Read More »